United Orthopedic Corporation (TPEX:4129)

Market Cap	11.09B
Revenue (ttm)	5.09B
Net Income (ttm)	497.37M
Shares Out	96.44M
EPS (ttm)	5.15
PE Ratio	22.34
Forward PE	n/a
Dividend	4.00 (3.52%)
Ex-Dividend Date	Jul 23, 2025

Volume	223,216
Average Volume	593,304
Open	115.50
Previous Close	115.00
Day's Range	114.50 - 116.00
52-Week Range	77.30 - 117.50
Beta	0.53
RSI	63.77
Earnings Date	Aug 12, 2025

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine produ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2024, United Orthopedic's revenue was 4.65 billion, an increase of 18.40% compared to the previous year's 3.93 billion. Earnings were 455.96 million, an increase of 20.11%.